This inventor holds 1 USPTO granted patent and 2 published patent applications, plus 1 CIPO patent. Top assignee: Bone Therapeutics S.a.. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Xuan Mai Nguyen: Innovator in Mesenchymal Stem Cell Research
Introduction
Xuan Mai Nguyen is a prominent inventor based in Woluwé-Saint-Pierre, Belgium. He has made significant contributions to the field of stem cell research, particularly in the differentiation of mesenchymal stem cells (MSC). His innovative methods aim to enhance the transplantation properties of MSC-derived cells.
Latest Patents
Xuan Mai Nguyen holds a patent for "Methods for differentiating mesenchymal stem cells." This patent discloses a method for obtaining MSC-derived cells with improved transplantation properties. The method includes a cell size reduction step, characterized by contacting MSC or MSC-derived cells in vitro or ex vivo with heparin or a derivative or analogue thereof at a concentration of at least 0.01 IU/ml. Additionally, the application provides a method for obtaining mesenchymal stem cell-derived cells from MSC by contacting MSC in vitro or ex vivo with FGF-2, TGF-β, and at least 0.01 IU/ml heparin or a derivative or analogue thereof. The invention also encompasses the so-obtained cells and cell populations, along with further products comprising such and their uses.
Career Highlights
Xuan Mai Nguyen is associated with Bone Therapeutics S.A., where he continues to advance his research in stem cell therapies. His work is pivotal in developing innovative solutions for regenerative medicine.
Collaborations
He collaborates with notable colleagues, including Sandra Pietri and Enrico Bastianelli, contributing to a dynamic research environment focused on stem cell applications.
Conclusion
Xuan Mai Nguyen's contributions to mesenchymal stem cell research exemplify the potential of innovative methods in regenerative medicine. His work not only enhances our understanding of stem cell differentiation but also paves the way for future advancements in therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile